Life science intelligence at your fingertips
BenevolentAI is a clinical-stage, AI-enabled drug discovery and development company listed on Euronext Amsterdam. Founded in 2013, the company uses its proprietary Benevolent Platform — built on a decade of investment in knowledge graphs and ontologies — to integrate life science data and augment scientific decision-making. Headquartered in London with offices in Cambridge and New York, BenevolentAI partners with pharmaceutical companies and pursues its own pipeline for complex diseases.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account